Invesco’s Disc Medicine IRON Stock Holding History

Invesco’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	42,057 +11,419	+37%	+$785K	﹤0.01%	2412
2026 Q1	$1.96M	Sell	30,638 -30,432	-50%	-$2.11M	﹤0.01%	2552
2025 Q4	$4.85M	Buy	61,070 +39,627	+185%	+$3.35M	﹤0.01%	2254
2025 Q3	$1.42M	Buy	21,443 +4,626	+28%	+$275K	﹤0.01%	2769
2025 Q2	$891K	Buy	16,817 +2,983	+22%	+$140K	﹤0.01%	2899
2025 Q1	$687K	Buy	13,834 +2,953	+27%	+$164K	﹤0.01%	3023
2024 Q4	$690K	Buy	10,881 +5,253	+93%	+$304K	﹤0.01%	3084
2024 Q3	$277K	Sell	5,628 -10	-0.2%	-$469	﹤0.01%	3442
2024 Q2	$254K	Sell	5,638 -65,797	-92%	-$2.24M	﹤0.01%	3547
2024 Q1	$4.45M	Sell	71,435 -42,633	-37%	-$2.76M	﹤0.01%	2308
2023 Q4	$6.59M	Sell	114,068 -47,145	-29%	-$2.41M	﹤0.01%	2088
2023 Q3	$7.57M	Buy	161,213 +50,581	+46%	+$2.53M	﹤0.01%	1944
2023 Q2	$4.91M	Buy	+110,632	New	+$3.93M	﹤0.01%	2249

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's IRON Position: Q2 2026 in Review

Invesco increased its Disc Medicine (IRON) stake by 37% in Q2 2026, buying an estimated $785K and bringing the position to 42,057 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2412.

Invesco first reported a position in IRON in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.57M in Q3 2023. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Invesco held 42,057 shares of Disc Medicine worth $3.08M as of Q2 2026.
Invesco bought 11,419 Disc Medicine shares in Q2 2026, an estimated $785K.
Disc Medicine made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2412 holding.
Invesco first reported a position in Disc Medicine in Q2 2023 and has held it in 13 quarters since.
Invesco's Disc Medicine position peaked at $7.57M in Q3 2023.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.